Related Experiment Video

Updated: Jun 5, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Optimal management of familial hypercholesterolemia: treatment and management strategies

Mohammad Hassan Nemati1, Behrooz Astaneh

  • 1Cardiac Surgery Department, Faghihi Hospital, Shiraz, Iran.

Vascular Health and Risk Management
|December 31, 2010
PubMed

Insights

Familial hypercholesterolemia, an inherited condition causing high cholesterol, requires diverse treatments. This review explores optimal management strategies for this serious genetic disorder.

Area of Science:

  • Genetics and Cardiovascular Medicine

Background:

  • Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder.
  • Caused by mutations in low-density lipoprotein receptor genes, leading to elevated LDL cholesterol.
  • Results in premature coronary atherosclerosis and increased risk of cardiac death, especially in homozygous cases.

Purpose of the Study:

  • To clinically review current treatment and management strategies for FH.
  • To provide insights into the optimal management of familial hypercholesterolemia.

Main Methods:

  • Clinical review of existing literature on FH treatment.
  • Analysis of various therapeutic options including diet, pharmacologic therapy, apheresis, and transplantation.

Main Results:

  • FH is characterized by significantly elevated total and LDL cholesterol levels.
  • Treatment options vary in efficacy and invasiveness.
  • Management strategies aim to mitigate the risk of premature cardiovascular events.

Conclusions:

  • Optimal management of FH involves a multi-faceted approach tailored to individual patient needs.
  • Early diagnosis and consistent treatment are crucial for improving outcomes.
  • Further research may refine therapeutic strategies for FH.

Keywords:
Iranfamilial hypercholesterolemiaheterozygotehomozygote

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...